GLOBUS MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
GLOBUS MEDICAL, INC. (GMED) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $8.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-06
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $8.50M, a 608.33% increase year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $22.00M, a 80.33% increase year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $41.80M, a 19.31% decline year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $2.20M, a 84.29% decline year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $57.50M, a 24.04% decline from fiscal 2024.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $75.70M, a 600.93% increase from fiscal 2023.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $10.80M, a 58.94% decline from fiscal 2022.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $26.30M, a 63.11% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.50M 10-Q · filed 2026-08-06 | $30.50M 10-Q · filed 2026-08-06 | $72.30M derived: sum of 3 quarters · filed 2026-08-06 | $74.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $22.00M 10-Q · filed 2026-05-07 | $63.80M derived: sum of 2 quarters · filed 2026-05-07 | $66.00M derived: sum of 3 quarters · filed 2026-05-07 | $67.20M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $41.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $44.00M derived: sum of 2 quarters · filed 2026-02-24 | $45.20M derived: sum of 3 quarters · filed 2026-08-06 | $57.50M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $2.20M 10-Q · filed 2025-11-06 | $3.40M derived: sum of 2 quarters · filed 2026-08-06 | $15.70M 10-Q · filed 2025-11-06 | $67.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.20M 10-Q · filed 2026-08-06 | $13.50M 10-Q · filed 2026-08-06 | $65.20M derived: sum of 3 quarters · filed 2026-08-06 | $79.20M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $12.20M 10-Q · filed 2026-05-07 | $64.00M derived: sum of 2 quarters · filed 2026-05-07 | $78.00M derived: sum of 3 quarters · filed 2026-05-07 | $85.10M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $51.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $65.80M derived: sum of 2 quarters · filed 2026-02-24 | $72.90M derived: sum of 3 quarters · filed 2026-02-24 | $75.70M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $14.00M 10-Q · filed 2025-11-06 | $21.10M derived: sum of 2 quarters · filed 2025-11-06 | $23.90M 10-Q · filed 2025-11-06 | $24.40M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $7.10M 10-Q · filed 2025-08-07 | $9.90M 10-Q · filed 2025-08-07 | $10.40M derived: sum of 3 quarters · filed 2026-02-24 | $12.60M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $2.80M 10-Q · filed 2025-05-08 | $3.30M derived: sum of 2 quarters · filed 2026-02-24 | $5.50M derived: sum of 3 quarters · filed 2026-02-24 | $8.30M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.70M derived: sum of 2 quarters · filed 2026-02-24 | $5.50M derived: sum of 3 quarters · filed 2026-02-24 | $10.80M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $2.20M 10-Q · filed 2024-11-05 | $5.00M derived: sum of 2 quarters · filed 2024-11-05 | $10.30M 10-Q · filed 2024-11-05 | $21.30M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $2.80M 10-Q · filed 2024-08-06 | $8.10M 10-Q · filed 2024-08-06 | $19.10M derived: sum of 3 quarters · filed 2025-02-20 | $27.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $5.30M 10-Q · filed 2024-05-07 | $16.30M derived: sum of 2 quarters · filed 2025-02-20 | $24.20M derived: sum of 3 quarters · filed 2025-02-20 | $26.90M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $18.90M derived: sum of 2 quarters · filed 2025-02-20 | $21.60M derived: sum of 3 quarters · filed 2025-02-20 | $26.30M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $7.90M 10-Q · filed 2023-11-07 | $10.60M derived: sum of 2 quarters · filed 2023-11-07 | $15.30M 10-Q · filed 2023-11-07 | $17.70M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $2.70M 10-Q · filed 2023-08-03 | $7.40M 10-Q · filed 2023-08-03 | $9.80M derived: sum of 3 quarters · filed 2024-02-21 | $43.60M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $4.70M 10-Q · filed 2023-05-04 | $7.10M derived: sum of 2 quarters · filed 2024-02-21 | $40.90M derived: sum of 3 quarters · filed 2024-02-21 | $65.90M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $36.20M derived: sum of 2 quarters · filed 2024-02-21 | $61.20M derived: sum of 3 quarters · filed 2024-02-21 | $71.30M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $33.80M 10-Q · filed 2022-11-08 | $58.80M derived: sum of 2 quarters · filed 2022-11-08 | $68.90M 10-Q · filed 2022-11-08 | $105.60M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $25.00M 10-Q · filed 2022-08-04 | $35.10M 10-Q · filed 2022-08-04 | $71.80M derived: sum of 3 quarters · filed 2023-02-21 | $95.10M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $10.10M 10-Q · filed 2022-05-10 | $46.80M derived: sum of 2 quarters · filed 2023-02-21 | $70.10M derived: sum of 3 quarters · filed 2023-02-21 | $82.80M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $60.00M derived: sum of 2 quarters · filed 2023-02-21 | $72.70M derived: sum of 3 quarters · filed 2023-02-21 | $76.10M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $23.30M 10-Q · filed 2021-11-04 | $23.27M 10-Q · filed 2020-10-28 | $36.00M derived: sum of 2 quarters · filed 2021-11-04 | $39.40M 10-Q · filed 2021-11-04 | $39.42M 10-Q · filed 2020-10-28 | $51.27M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-06-30 | $12.70M 10-Q · filed 2021-08-04 | $12.68M 10-Q · filed 2020-08-05 | $16.20M 10-Q · filed 2021-08-04 | $16.16M 10-Q · filed 2020-08-05 | $27.97M derived: sum of 3 quarters · filed 2022-02-17 | $35.53M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-03-31 | $3.50M 10-Q · filed 2021-05-04 | $3.48M 10-Q · filed 2020-05-07 | $15.27M derived: sum of 2 quarters · filed 2022-02-17 | $22.83M derived: sum of 3 quarters · filed 2022-02-17 | $25.09M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2019-12-31 | $11.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $19.33M derived: sum of 2 quarters · filed 2022-02-17 | $21.59M derived: sum of 3 quarters · filed 2022-02-17 | $31.30M 10-K · filed 2022-02-17 | $31.32M 10-K · filed 2020-02-20 | |||
| 2019-09-30 | $7.57M 10-Q · filed 2020-10-28 | $8.85M 10-Q · filed 2019-11-06 | $9.82M derived: sum of 2 quarters · filed 2020-10-28 | $19.53M 10-Q · filed 2020-10-28 | $18.20M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-06-30 | $2.26M 10-Q · filed 2020-08-05 | $10.68M 10-Q · filed 2020-08-05 | $10.64M derived: sum of 3 quarters · filed 2021-02-17 | $18.20M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $8.42M 10-Q · filed 2020-05-07 | $8.38M derived: sum of 2 quarters · filed 2021-02-17 | $15.94M derived: sum of 3 quarters · filed 2021-02-17 | $49.25M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | -$45.00K derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17 | $7.52M derived: sum of 2 quarters · filed 2021-02-17 | $40.83M derived: sum of 3 quarters · filed 2021-02-17 | $59.30M 10-K · filed 2021-02-17 | $59.34M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | $7.57M 10-Q · filed 2019-11-06 | $40.87M derived: sum of 2 quarters · filed 2019-11-06 | $59.34M 10-K · filed 2020-02-20 | $55.72M 10-Q · filed 2018-11-08 | $61.91M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $33.30M 10-Q · filed 2019-08-01 | $48.15M 10-Q · filed 2019-08-01 | $54.35M derived: sum of 3 quarters · filed 2020-03-02 | $55.61M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $14.85M 10-Q · filed 2019-05-02 | $21.04M derived: sum of 2 quarters · filed 2020-03-02 | $22.30M derived: sum of 3 quarters · filed 2020-03-02 | $25.18M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $6.19M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $7.46M derived: sum of 2 quarters · filed 2020-03-02 | $10.33M derived: sum of 3 quarters · filed 2020-03-02 | $12.22M 10-K/A · filed 2020-03-02 | ||||
| 2017-09-30 | $1.26M 10-Q · filed 2018-11-08 | $4.13M derived: sum of 2 quarters · filed 2018-11-08 | $6.02M 10-Q · filed 2018-11-08 | $7.46M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-06-30 | $2.87M 10-Q · filed 2018-08-02 | $4.76M 10-Q · filed 2018-08-02 | $6.20M derived: sum of 3 quarters · filed 2019-02-21 | $8.96M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-03-31 | $1.89M 10-Q · filed 2018-05-03 | $3.33M derived: sum of 2 quarters · filed 2019-02-21 | $6.09M derived: sum of 3 quarters · filed 2019-02-21 | $7.98M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2016-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $4.20M derived: sum of 2 quarters · filed 2019-02-21 | $6.09M derived: sum of 3 quarters · filed 2019-02-21 | $8.82M 10-K · filed 2019-02-21 | ||||
| 2016-09-30 | $2.76M 10-Q · filed 2017-11-09 | $4.66M derived: sum of 2 quarters · filed 2017-11-09 | $7.39M 10-Q · filed 2017-11-09 | $8.67M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $1.90M 10-Q · filed 2017-08-03 | $4.63M 10-Q · filed 2017-08-03 | $5.91M derived: sum of 3 quarters · filed 2018-02-22 | $8.67M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $2.73M 10-Q · filed 2017-05-04 | $4.02M derived: sum of 2 quarters · filed 2018-02-22 | $6.78M derived: sum of 3 quarters · filed 2018-02-22 | $9.46M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $4.04M derived: sum of 2 quarters · filed 2018-02-22 | $6.72M derived: sum of 3 quarters · filed 2018-02-22 | $9.98M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $2.76M 10-Q · filed 2016-11-09 | $5.44M derived: sum of 2 quarters · filed 2016-11-09 | $8.70M 10-Q · filed 2016-11-09 | $12.16M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $2.68M 10-Q · filed 2016-07-27 | $5.94M 10-Q · filed 2016-07-27 | $9.40M derived: sum of 3 quarters · filed 2017-03-16 | $10.26M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $3.26M 10-Q · filed 2016-05-04 | $6.73M derived: sum of 2 quarters · filed 2017-03-16 | $7.58M derived: sum of 3 quarters · filed 2017-03-16 | $12.19M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $4.32M derived: sum of 2 quarters · filed 2017-03-16 | $8.93M derived: sum of 3 quarters · filed 2017-03-16 | $20.22M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $853.00K 10-Q · filed 2015-11-04 | $5.47M derived: sum of 2 quarters · filed 2015-11-04 | $16.75M 10-Q · filed 2015-11-04 | $19.46M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $4.61M 10-Q · filed 2015-07-31 | $15.90M 10-Q · filed 2015-07-31 | $18.61M derived: sum of 3 quarters · filed 2016-02-29 | $23.63M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $11.28M 10-Q · filed 2015-05-05 | $13.99M derived: sum of 2 quarters · filed 2016-02-29 | $19.02M derived: sum of 3 quarters · filed 2016-02-29 | $29.40M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $7.74M derived: sum of 2 quarters · filed 2016-02-29 | $18.11M derived: sum of 3 quarters · filed 2016-02-29 | $25.03M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $5.03M 10-Q · filed 2014-10-31 | $15.41M derived: sum of 2 quarters · filed 2014-10-31 | $22.33M 10-Q · filed 2014-10-31 | $23.76M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $10.38M 10-Q · filed 2014-08-06 | $17.30M 10-Q · filed 2014-08-06 | $18.74M derived: sum of 3 quarters · filed 2015-02-26 | $27.42M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $6.92M 10-Q · filed 2014-04-30 | $8.36M derived: sum of 2 quarters · filed 2015-02-26 | $17.04M derived: sum of 3 quarters · filed 2015-02-26 | $17.70M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $10.12M derived: sum of 2 quarters · filed 2015-02-26 | $10.78M derived: sum of 3 quarters · filed 2015-02-26 | $12.51M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $8.68M 10-Q · filed 2013-10-31 | $9.34M derived: sum of 2 quarters · filed 2013-10-31 | $11.07M 10-Q · filed 2013-10-31 | $11.40M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $656.00K 10-Q · filed 2013-08-02 | $2.39M 10-Q · filed 2013-08-02 | $2.72M derived: sum of 3 quarters · filed 2014-03-14 | $2.91M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $1.73M 10-Q · filed 2013-05-03 | $2.06M derived: sum of 2 quarters · filed 2014-03-14 | $2.25M derived: sum of 3 quarters · filed 2014-03-14 | $2.50M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $525.00K derived: sum of 2 quarters · filed 2014-03-14 | $774.00K derived: sum of 3 quarters · filed 2014-03-14 | $969.00K 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $192.00K 10-Q · filed 2012-11-02 | $441.00K derived: sum of 2 quarters · filed 2012-11-02 | $636.00K 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $249.00K 10-Q/A · filed 2012-09-19 | $444.00K 10-Q/A · filed 2012-09-19 | ||||||
| 2010-12-31 | $5.05M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |